High Potent Clinical Trial Manufacturing. Let's talk future

PCI provides a comprehensive service at each stage of the product lifecycle for a wide range of dosage forms, in full compliance with GMP regulatory standards for both highly potent and non potent drug products.

Our strength lies in the integrated nature of our services, combining formulation and analytical development with GMP clinical manufacturing and packaging through a full cross functional project team, coordinated by an experienced team of project managers.

Utilizing our state-of-the-art facilities, we offer unrivaled capabilities with a focus on customer needs. We provide clinical manufacturing of multiple dosage forms for investigational use including solid oral dose, liquids, semi-solids, and aseptic fill finish processing.

All clinical manufacturing services are fully supported by a dedicated and experienced team of Qualified Persons, a full analytical laboratory, and a GMP-compliant warehouse.

High Potent Microdosing Technology, Xcelodose®

Delivering drug directly into capsules or vials using contained microdosing technology removes the need for initial formulation development and associated stability, leading to faster first-in-man studies and cost efficiencies.

The fully programmable system ensures exceptional levels of accuracy and precision whilst minimizing wastage of drug substance. We are proud to offer multiple options of microdosing technology, delivering individual client volume requirements.

PCI has further invested in Xcelohood™ and Xceloprotect™ technology for microdosing technologies, further enhancing our contained solutions for the development and manufacturing of highly potent drug products.